[Sinovac Reports Unaudited First Quarter 2020 Financial Results BEIJING, China, June 30, 2020 / Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first q]
[Sinovac Reports Unaudited First Quarter 2020 Financial Results BEIJING, China, June 30, 2020 / Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first q]
[(function() { var hostName = window.location.hostname; var browserAccepted = function() { var ua = window.navigator.userAgent; var trident = ua.indexOf('Trident/'); //IE 11; var msie = ua.indexOf('MSIE '); // IE 10 or older if (msie > 0) { return false; } return true; }(); var pathToLibs = './js'; v]
[WEIBO CORPORATION $ · · % Notes due 20 · ________ Underwriting Agreement June [ · Goldman Sachs (Asia) L.L.C. 68/F, Cheung Kong Center 2 Queens Road Central Hong Kong Representative As representative (the Ladies and Gentlemen: Company Agreement Underwriters Weibo Corporation, an exempted company ]
[(function() { var hostName = window.location.hostname; var browserAccepted = function() { var ua = window.navigator.userAgent; var trident = ua.indexOf('Trident/'); //IE 11; var msie = ua.indexOf('MSIE '); // IE 10 or older if (msie > 0) { return false; } return true; }(); var pathToLibs = './js'; v]
[WEIBO CORPORATION $ · · % Notes due 20 · ________ Underwriting Agreement June [ · Goldman Sachs (Asia) L.L.C. 68/F, Cheung Kong Center 2 Queens Road Central Hong Kong Representative As representative (the Ladies and Gentlemen: Company Agreement Underwriters Weibo Corporation, an exempted company ]
[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]
[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]
[Specialty Chemical Company China XD Plastics Announces First Quarter 2020 Financial Results – Revenue of $144.8 million – HARBIN, China, June 29, 2020 /PRNewswire/ -- China XD Plastics Company Limited (NASDAQ: CXDC) (“China XD,” the “Company” or “we”), one of China’s leading specialty chemical compa]
